Phio is a preclinical/early-clinical company with no PDUFA on this date; the large move was unrelated to any FDA decision — archive 'CRL' label appears erroneous.
Historical price action; green = local high, red = low/sell-off.
FDA decision date2025-07-28
Outcome✗ CRL⚠ label corrected
Decision-day move-7.7%
T-120 run-up (low→high)+128.0% ($1.01→$2.96)
CRL reasonPhio is a preclinical/early-clinical company with no PDUFA on this date; the large move was unrelated to any FDA decision — archive 'CRL' label appears erroneous.
ValidationOutcome consistent with price; primary-source verification in progress.